Lung cancer risk in patients with multiple sclerosis: a Mendelian randomization analysis-Reference-Cited by-同舟云学术

Lung cancer risk in patients with multiple sclerosis: a Mendelian randomization analysis

Published:2021-06 Issue: Volume:51 Page:102927
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Ge Fan^ORCID,Huo Zhenyu,Li Caichen,Wang Runchen,Wang Rui^ORCID,Liu Yeling,Chen Jiana,Lu Yi,Wen Yaokai,Jiang Yu,Peng Haoxin,Wu Xiangrong,Liang Hengrui,He Jianxing,Liang Wenhua

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference73 articles.

1. Airway Epithelial Barrier Dysfunction in Chronic Obstructive Pulmonary Disease: Role of Cigarette Smoke Exposure;Aghapour;American journal of respiratory cell and molecular biology,2018

2. Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation;Andlauer;Science advances,2016

3. Th2 bias of CD4+ NKT cells derived from multiple sclerosis in remission;Araki;International immunology,2003

4. Cancer risk among patients with multiple sclerosis and their parents;Bahmanyar;Neurology,2009

5. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis;Beecham;Nature genetics,2013

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An exploration of causal relationships between nine neurological diseases and the risk of breast cancer: a Mendelian randomization study;Aging;2024-04-24

2. Association between multiple sclerosis and cancer risk: A two-sample Mendelian randomization study;PLOS ONE;2024-03-19

3. Health, Wellness, and the Effect of Comorbidities on the Multiple Sclerosis Disease Course;Neurologic Clinics;2024-02

4. Role of rs873601 Polymorphisms in Prognosis of Lung Cancer Patients Treated with Platinum-Based Chemotherapy;Biomedicines;2023-11-24

5. Heritable Traits and Lung Cancer Risk: A Two-Sample Mendelian Randomization Study;Cancer Epidemiology, Biomarkers & Prevention;2023-08-02